Predicting survival in urothelial cancer patients after immunotherapy using real-world data

被引：2

作者：

Elumalai, T. ^{[1
]}

Aversa, C. ^{[2
]}

Buijtenhuijs, B. ^{[1
]}

Conroy, R. ^{[1
]}

Croxford, W. ^{[1
]}

Das, A. ^{[3
]}

Doss, G. ^{[2
]}

Enting, D. ^{[4
]}

Kitetere, E. ^{[5
]}

Sanderson, B. ^{[5
]}

Vasudev, N. ^{[6
]}

Mistry, H. ^{[7
]}

Choudhury, A. ^{[7
]}

机构：

[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England

[2] Guys & St Thomas NHS Fdn Trust, Dept Clin Oncol, London, England

[3] St Jamess Inst Oncol, Dept Clin Oncol, Leeds, W Yorkshire, England

[4] Guys & St Thomas Hosp NHS Trust, Dept Oncol, London, England

[5] Royal Marsden NHS Fdn Trust, Dept Clin Oncol, London, England

[6] Royal Preston Hosp, Dept Clin Oncol, Rosemere Canc Ctr, Preston, Lancs, England

[7] Univ Manchester, Div Canc Sci, Manchester, Lancs, England

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.837

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

765P

引用

页码：S590 / S590

页数：1

共 50 条

[1] Real-world survival outcomes in patients with advanced urothelial cancer in Germany
Niegisch, G.
Gerullis, H.
Lin, S-W.
Pavlova, J.
Gondos, A.
Rudolph, A.
Haas, G.
Hennies, N.
Kramer, M. W.
ANNALS OF ONCOLOGY, 2017, 28
[2] The real-world impact of cancer immunotherapy on the survival of patients with metastatic melanoma
Donia, M.
Ellebaek, E.
Oellegaard, T. H.
Duval, L.
Aaby, J. B.
Hoejberg, L.
Koehler, U. H.
Schmidt, H.
Bastholt, L.
Svane, I-M.
ANNALS OF ONCOLOGY, 2018, 29
[3] Real-World Data Showcase Survival Outcomes After Immunotherapy/TKI Regimens in RCC
Mikhael, Joseph
Baljevic, Muhamed
Landgren, C. Ola
Valdes, Cesar Rodriquez
Usmani, Saad Z.
Callander, Natalie
Richter, Joshua
ONCOLOGY-NEW YORK, 2024, 38 (09):
[4] Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis
Jin, Yizi
Lin, Mingxi
Luo, Zhiguo
Hu, Xichun
Zhang, Jian
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
[5] Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patients: a machine learning approach using real-world data
Pan, Lingyun
Mu, Li
Lei, Haike
Miao, Siwei
Hu, Xiaogang
Tang, Zongwei
Chen, Wanyi
Wang, Xiaoxiao
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024,
[6] Real-world data of immunotherapy in patients over 65 years old with lung cancer
Nunez-Garcia, B.
Garitaonaindia Diaz, Y.
Martinez-Cutillas, M.
Blanco, M.
Aguado, R.
Morito Aguilar, A. M.
Traseira, C.
Visedo, G.
Calvo, V.
Franco, F.
Provencio Pulla, M.
ANNALS OF ONCOLOGY, 2020, 31 : S1439 - S1439
[7] Influence of psychiatric disorders on survival in patients with lung cancer: Real-world data
Kovacevic, T.
Bokan, D.
Malbasa, J. Djekic
Zaric, B.
Bursac, D.
Stojanovic, G.
Simurdic, P. V.
Stojsic, V.
ANNALS OF ONCOLOGY, 2023, 34 : S1090 - S1090
[8] Real-world data registry on patients treated with enfortumab vedotin in metastaic urothelial cancer in Austria
Niedersuess-Beke, D.
Krauter, J.
Shariat, S.
Pichler, R.
Barth, D.
Pichler, M.
Weibrecht, S.
Marszalek, M.
Stoiber, F.
Mayerhofer, K.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 323 - 323
[9] Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy
Elumalai, T.
Croxford, W.
Buijtenhuijs, B.
Conroy, R.
Sanderson, B.
Enting, D.
Aversa, C.
Doss, G.
Das, A.
Vasudev, N. S.
Kitetere, E.
Tolan, S.
Law, A.
Hoskin, P.
Mistry, H.
Choudhury, A.
CLINICAL ONCOLOGY, 2022, 34 (10) : 642 - 652
[10] Cancer Risk in Patients with Gaucher Disease Using Real-World Data
Revel-Vilk, Shoshana
Zimran, Ari
Istaiti, Majdolen
Manor, Orly
Shalev, Varda
Azani, Litat
Chodick, Gabriel
Paltiel, Ora
BLOOD, 2023, 142

← 1 2 3 4 5 →